Pharmasset Inc
SEC CIK 1301081 · VRUS · last insider filing 2012-01-17
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Hahn Elliot F | Director | filed 2007 - 2012 |
| Inouye Michael K | Director | filed 2007 - 2012 |
| Conrad Herbert J | Director | filed 2008 - 2012 |
| Williamson Robert F III | Director | filed 2007 - 2012 |
| Price P Schaefer | Director · President and CEO | filed 2007 - 2012 |
| Carney William J | Director | filed 2007 - 2012 |
| Burrill Steven | Director | filed 2007 - 2010 |
| Price Fredric D | Director | filed 2007 - 2010 |
| Gadicke Ansbert | Director | filed 2007 - 2008 |
| Goll Alexandra | Director | filed 2007 - 2007 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Leutzinger Kurt | Executive VP & CFO | filed 2007 - 2012 |
| Otto Michael J. | Exec.VP,Pharm.Research | filed 2007 - 2012 |
| Berrey M Michelle | VP, Clinical Development & CMO | filed 2007 - 2012 |
| Rogers Michael D. | Chief Development Officer | filed 2007 - 2012 |
| Lubetkin Paul | Executive VP & General Counsel | filed 2008 - 2009 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.